Oryzon Genomics SA (ORY) — Cash Flow Quality Index
Oryzon Genomics SA (ORY) has a Cash Flow Quality Index of -2.29x as of June 2023. Operating cash flow of €-2.41 Million is below net income of €1.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Oryzon Genomics SA to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oryzon Genomics SA Cash Flow Quality Index (2014–2014)
Historical Cash Flow Quality Index for Oryzon Genomics SA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ORY cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Oryzon Genomics SA (2014–2014)
Year-by-year earnings quality comparison for Oryzon Genomics SA. For live market cap and the full company financial profile, see Oryzon Genomics SA market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | 1.82x | €12.13 Million | €6.65 Million | — |